Citizens Business Bank Eli Lilly & CO Transaction History

Citizens Business Bank

$466 Million
Q1 2024

A detailed history of Citizens Business Bank transactions in Eli Lilly & CO stock. As of the latest transaction made, Citizens Business Bank holds 954 shares of LLY stock, worth $889,605. This represents 0.16% of its overall portfolio holdings.

Number of Shares

954

Previous 1,093 12.72%

Holding current value

$889,605

Previous $637,000 16.48%

% of portfolio

0.16%

Previous 0.15%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 17, 2024	SELL	$592.2 - $792.28 $82,315 - $110,126	-139 Reduced 12.72%	954 $742,000
Q4 2023 Feb 05, 2024	SELL	$525.19 - $619.13 $175,938 - $207,408	-335 Reduced 23.46%	1,093 $637,000
Q3 2023 Nov 02, 2023	SELL	$434.7 - $599.3 $118,673 - $163,608	-273 Reduced 16.05%	1,428 $767,000
Q2 2023 Aug 07, 2023	BUY	$350.74 - $468.98 $325,135 - $434,744	927 Added 119.77%	1,701 $797,000
Q1 2023 May 09, 2023	BUY	$310.63 - $364.82 $31,994 - $37,576	103 Added 15.35%	774 $265,000

Q4 2022 Feb 07, 2023	BUY	$321.55 - $374.67 $10,932 - $12,738	34 Added 5.34%	671 $245,000
Q3 2022 Nov 03, 2022	BUY	$296.48 - $337.87 $188,857 - $215,223	637 New	637 $206,000
Q2 2022 Nov 18, 2022	BUY	$278.73 - $327.27 $1,393 - $1,636	5 Added 0.66%	768 $249,000
Q1 2022 Nov 18, 2022	BUY	$234.69 - $291.66 $179,068 - $222,536	763 New	763 $219,000
Q1 2019 Nov 18, 2022	SELL	$111.31 - $131.02 $692,014 - $814,551	-6,217 Closed	0 $0
Q4 2018 Nov 18, 2022	SELL	$105.9 - $118.64 $735,369 - $823,836	-6,944 Reduced 52.76%	6,217 $719,000
Q3 2018 Nov 18, 2022	SELL	$85.86 - $107.31 $721,224 - $901,404	-8,400 Reduced 38.96%	13,161 $1.41 Million
Q2 2018 Nov 18, 2022	SELL	$75.7 - $86.88 $425,661 - $488,526	-5,623 Reduced 20.68%	21,561 $1.84 Million
Q1 2018 Nov 18, 2022	BUY	$74.21 - $87.6 $854,082 - $1.01 Million	11,509 Added 73.42%	27,184 $2.1 Million
Q4 2017 Nov 18, 2022	BUY	$81.94 - $87.89 $655,520 - $703,120	8,000 Added 104.23%	15,675 $1.32 Million
Q3 2017 Nov 18, 2022	BUY	$77.07 - $85.54 $30,827 - $34,216	400 Added 5.5%	7,675 $657,000
Q2 2017 Nov 18, 2022	BUY	N/A	6,638 Added 1042.07%	7,275 $599,000
Q1 2017 Nov 18, 2022	SELL	N/A	-5,100 Reduced 41.21%	7,275 $612,000
Q4 2016 Nov 18, 2022	SELL	N/A	-225 Reduced 1.79%	12,375 $910,000
Q3 2016 Nov 18, 2022	SELL	N/A	-500 Reduced 3.82%	12,600 $1.01 Million
Q2 2016 Nov 18, 2022	SELL	N/A	-300 Reduced 2.24%	13,100 $1.03 Million
Q1 2016 Nov 18, 2022	SELL	N/A	-1,520 Reduced 10.19%	13,400 $965,000
Q4 2015 Nov 18, 2022	BUY	N/A	1,000 Added 7.18%	14,920 $1.26 Million
Q3 2015 Nov 18, 2022	SELL	N/A	-916 Reduced 6.17%	13,920 $1.17 Million
Q2 2015 Nov 18, 2022	SELL	N/A	-1,132 Reduced 7.09%	14,836 $1.24 Million
Q1 2015 Nov 18, 2022	SELL	N/A	-1,095 Reduced 6.42%	15,968 $1.16 Million
Q3 2014 Nov 18, 2022	SELL	N/A	-791 Reduced 4.43%	17,063 $1.11 Million
Q2 2014 Nov 18, 2022	SELL	N/A	-300 Reduced 1.65%	17,854 $1.11 Million
Q1 2014 Nov 18, 2022	BUY	N/A	17,517	18,154 $1.07 Million

Others Institutions Holding LLY

# of Institutions

3,728

Shares Held

738M

Call Options Held

7.09M

Put Options Held

7.24M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $886B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Citizens Business Bank, based on Form 13F filings with the SEC.

News

Stay updated on Citizens Business Bank with notifications on news.

Account

Citizens Business Bank Eli Lilly & CO Transaction History